Results: Glucocorticoid treatment alone resulted in increased expression of GRα-A, GRα-C3, GRα-D1 and D3 isoforms. LPS treatment alone resulted into an increased expression of GRαD1, 68/69 kDa, and DUSP1 protein, while ZFP36 protein was decreased. A significant increase in TNFα mRNA was also observed. The combination of LPS and glucocorticoids resulted into a decreased GRαD1 and TNFα mRNA.
WRITE IT TO GET IT RIGHT: COMPLIANCE WITH DOCUMENTATION IN OPERATIVE VAGINAL DELIVERIES
King Edward Memorial Hospital, Perth, Australia Background: Documentation is a crucial part of any operative delivery. Accurate and timely documentation serves many purposes including serving as a clinical prompt for the operator, providing information to the neonatologist, and ensuring medico-legal security for patients, practitioners and institutions. Accuracy of documentation is improved with the use of a pro forma. Our unit has an operative delivery pro forma and our guidelines recommend its completion for 100% of cases. Our risk management systems identified a lack of documentation in cases of neonatal trauma related to operative vaginal delivery. This audit sought to investigate compliance with our guideline in order to target education and training regarding the importance of documentation completion.
Method: Using the hospital's delivery database, all operative deliveries within the 2016-2017 period were identified. From this population, 120 randomly selected deliveries were identified. The medical records of these file were then reviewed.
Results: The audit is currently underway. Initial data analysis suggests that poor documentation is a common problem, potentially contributing to ineffective communication, particularly between obstetric and neonatal teams.
Conclusions: Operative vaginal deliveries remain a high-risk area of practice. Accurate documentation is essential, with poor compliance having the potential to negatively impact patient safety. Support to medical staff is suggested to maximise documentation compliance. Background: Recently published studies have identified buprenorphine as an alternative to morphine for the treatment of NAS. Prior to implementation of novel treatments, baseline parameters for current practice are required. The aim of this study was to determine the length of treatment (LOT), length of stay (LOS) and compliance to prescribing guidelines for NAS treatment with oral morphine at a state-wide neonatal unit.
CLINICIANS' VIEW OF PARENTS' DECISION-MAKING NEEDS FOR AUTOPSY CONSENT AFTER STILLBIRTH
Methods: An audit of morphine use in neonates treated for NAS in 2016 and 2017 was conducted. Data was collected retrospectively from medical records of each neonate. Compliance to prescribing guidelines was assessed with respect to the initial morphine dose prescribed and the duration to wean the morphine dose.
Results: There were 25 neonates treated with oral morphine for NAS in 2016 and 2017. The median LOT and LOS were 26.58 days and 31 days respectively. Of the 25 neonates, 28% (7/25) received oral morphine on discharge with a median outpatient LOT of 18 days. The prescribing compliance to guidelines in respect to the initial morphine dose was 96% (24/25). Compliance to wean the morphine dose according to guidelines was 63%. There were 3 neonates (12%) that required adjunct treatment with phenobarbital.
Conclusion: This study has provided a baseline LOT and LOS for neonates treated with morphine for NAS at a state-wide neonatal unit. Initial morphine dosing was according to guidelines whereas compliance to wean morphine dose was outside guideline recommendations. The baseline parameters from this study can be used for comparison of any new treatments introduced.
